Ketotifen Fumarate is a second-generation non-bronchodilator antiasthmatic agent, H1-antihistamine, and potent mast cell stabilizer. It functions primarily by blocking histamine H1 receptors and preventing the degranulation and release of inflammatory mediators (such as histamines and leukotrienes) from mast cells.
In body composition, asthma/allergy management, and performance protocols, Ketotifen is widely known for its ability to resensitize beta-2 adrenergic receptors. When using beta-2 agonists (such as Clenbuterol or Albuterol), beta-2 receptors rapidly downregulate and become desensitized within 2–3 weeks. Ketotifen upregulates these receptors, allowing beta-2 agonists to remain effective for extended periods without requiring continuous off-cycles.
Key Benefits & Applications
-
Beta-2 Receptor Upregulation: Prevents and reverses the downregulation of $\beta_2$-adrenergic receptors caused by chronic beta-agonist use, restoring fat-burning and bronchodilating sensitivity.
-
Prolonged Fat-Loss Cycles: Enables extended protocols with agents like Clenbuterol or Albuterol without requiring the standard 2-weeks-on / 2-weeks-off cycling schedule.
-
Mast Cell Stabilization: Prevents mast cells from releasing histamines, leukotrienes, and inflammatory cytokines, making it effective for chronic allergic responses and asthma prophylaxis.
-
Potent Antihistamine Action: Blocks circulating histamine from binding to H1 receptors, alleviating symptoms like hives, itching, allergic rhinitis, and bronchospasm.
-
Sleep Enhancement: Possesses mild sedative properties that can help offset the central nervous system stimulation and insomnia associated with thermogenic fat burners.






Reviews
There are no reviews yet.